Literature DB >> 15606614

Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis.

S Yamashiro1, K Kawakami, K Uezu, T Kinjo, K Miyagi, K Nakamura, A Saito.   

Abstract

Diabetes mellitus is an important predisposing factor for tuberculosis. The aim of this study was to investigate the mechanism underlying this association using a murine model. Mice with streptozotocin-induced diabetes mellitus were prone to Mycobacterium tuberculosis infection, as indicated by increased numbers of live bacteria in lung, liver and spleen. In diabetic mice, the levels of IL-12 and IFN-gamma in the lung, liver and spleen were lower than those in control animals on day 14 postinfection, while the opposite was true for IL-4 levels in the lung and liver. The expression pattern of inducible nitric oxide synthase (iNOS), in the two mice types was as for IL-12 and IFN-gamma. In addition, peritoneal exudate cells obtained from diabetic mice produced lower amounts of IL-12 and NO than those from control mice, when stimulated in vitro with M. bovis BCG. Spleen cells from diabetic mice infected with M. tuberculosis produced a significantly lower amount of IFN-gamma upon restimulation with purified protein derivatives (PPD) than those from infected nondiabetic mice. Interestingly, addition of high glucose levels (33 mM) to the cultures of PPD-restimulated spleen cells reduced the synthesis of IFN-gamma only in diabetic mice, and not in nondiabetic mice. Finally, control of blood glucose levels by insulin therapy resulted in improvement of the impaired host protection and Th1-related cytokine synthesis. Our results suggest that the reduced production of Th1-related cytokines and NO account for the hampered host defense against M. tuberculosis infection under diabetic conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15606614      PMCID: PMC1809276          DOI: 10.1111/j.1365-2249.2005.02677.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  Effects of aminoguanidine on latent murine tuberculosis.

Authors:  J L Flynn; C A Scanga; K E Tanaka; J Chan
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

Review 2.  Nitric oxide and macrophage function.

Authors:  J MacMicking; Q W Xie; C Nathan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells.

Authors:  R Muniyappa; P R Srinivas; J L Ram; M F Walsh; J R Sowers
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

4.  Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C.

Authors:  J R Hill; G Kwon; C A Marshall; M L McDaniel
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

5.  Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice.

Authors:  N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis].

Authors:  K Tsukaguchi; H Okamura; M Ikuno; A Kobayashi; A Fukuoka; H Takenaka; C Yamamoto; T Tokuyama; Y Okamoto; A Fu; M Yoshikawa; T Yoneda; N Narita
Journal:  Kekkaku       Date:  1997-11

7.  Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12.

Authors:  K Kawakami; M Tohyama; X Qifeng; A Saito
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

8.  Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40.

Authors:  Yuki Kinjo; Kazuyoshi Kawakami; Kaori Uezu; Satomi Yara; Kazuya Miyagi; Yoshinobu Koguchi; Tomoaki Hoshino; Masaki Okamoto; Yusuke Kawase; Koichi Yokota; Kohichiro Yoshino; Kiyoshi Takeda; Shizuo Akira; Atsushi Saito
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

9.  Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis.

Authors:  R J North
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.

Authors:  A M Cooper; J Magram; J Ferrante; I M Orme
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  41 in total

Review 1.  Diabetes and Tuberculosis.

Authors:  Blanca I Restrepo
Journal:  Microbiol Spectr       Date:  2016-12

Review 2.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

Review 3.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

4.  Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea.

Authors:  Eun Hye Lee; Jung Mo Lee; Young Ae Kang; Ah Young Leem; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Song Yee Kim
Journal:  Lung       Date:  2017-02-09       Impact factor: 2.584

Review 5.  Diabetes and immunity to tuberculosis.

Authors:  Nuria Martinez; Hardy Kornfeld
Journal:  Eur J Immunol       Date:  2014-02-16       Impact factor: 5.532

6.  Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis.

Authors:  Therese Vallerskog; Gregory W Martens; Hardy Kornfeld
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

7.  Delayed activation of host innate immune pathways in streptozotocin-induced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei.

Authors:  Chui-Yoke Chin; Denise M Monack; Sheila Nathan
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

8.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

9.  Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis.

Authors:  Basirudeen Syed Ahamed Kabeer; Balambal Raman; Aleyamma Thomas; Venkatesan Perumal; Alamelu Raja
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

Review 10.  Impact of diabetes on the natural history of tuberculosis.

Authors:  Blanca I Restrepo; Larry S Schlesinger
Journal:  Diabetes Res Clin Pract       Date:  2014-07-14       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.